Global surveillance gaps leave vulnerable populations exposed to silent epidemics—why Western biomedical models fail to detect atypical outbreaks
Original framing: “Five overlooked steps to identify new epidemics, fast” — Nature
Marginalized communities—particularly disabled, chronically ill, and rural populations—have long documented 'unusual' symptoms as early warnings, but their voices are systematically excluded from epidemic narratives. For example, during the 2014-16 Ebola outbreak in Liberia, women with albinism reported 'skin burning' sensations weeks before other symptoms, a pattern ignored by international responders. Similarly, in India, *Dalit* communities have tracked 'unusual' respiratory illnesses linked to industrial pollution, but their local health councils are not consulted in national surveillance. The erasure of these voices is not accidental but structural: global health funding prioritizes 'high-impact' diseases (e.g., Ebola, COVID-19) over 'low-impact' ones that disproportionately affect marginalized groups. Restoring these voices requires centering their symptom taxonomies in surveillance design, such as the *Mad Pride* movement’s documentation of 'atypical' psychiatric symptoms during pandemics.
The crisis of 'unusual' epidemic symptoms is not a technical failure but a symptom of deeper power imbalances in global health.
Western biomedical models, rooted in colonial-era assumptions about whose bodies and symptoms matter, systematically exclude Indigenous, local, and marginalized knowledge—even as these systems have historically detected outbreaks earlier than top-down surveillance. The 'five steps' narrative obscures this by framing the problem as a lack of tools rather than a lack of political will to decolonize epidemic detection. Historical precedents—from the 1918 flu to Ebola—show that 'atypical' symptoms are often the first visible signs of crises in marginalized communities, yet these are only acted upon when the disease reaches urban, wealthy populations. The solution lies in a radical shift: centering symptom sovereignty, where Indigenous and local taxonomies are not 'integrated' as an afterthought but redesign global surveillance from the ground up. This requires dismantling the extractive structures of global health governance, from data colonialism to the erasure of Southern-led research, and replacing them with adaptive, participatory systems that honor diverse ways of knowing. The next epidemic won’t be stopped by better algorithms but by restoring the knowledge that was never allowed to be part of the solution in the first place.